Chemomab Therapeutics (CMMB) and Scipher Medicine have entered into an all-stock merger agreement, the companies said Wednesday.
Shares of Chemomab dropped 14% as intraday trading volume jumped to over 1.79 million from a daily average of about 75,000.
Saratoga Investment (SAR) reported a decline in fiscal Q1 net investment income per share late Tuesday, falling more than the market had anticipated.
Shares declined 13%, with intraday trading volume at over 645,000 after midday versus a daily average of about 101,000.
FuelCell Energy's (FCEL) shares slumped 11% amid heavy trading after the company said it priced an offering of about 10.7 million common shares at $21 each for gross proceeds of about $225 million.
More than 14.9 million shares of the company traded intraday compared with a daily average of about 11.3 million.
Price: $1.85, Change: $-0.92, Percent Change: -33.21%